As of Aug 24
| +0.005 / +1.06%|
The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 2.25, with a high estimate of 2.25 and a low estimate of 2.25. The median estimate represents a +373.68% increase from the last price of 0.48.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.